Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Trial Identifier:	D3461R00051
Sponsor:	AstraZeneca
Collaborator:	PPD
Start Date:	July 2025
Primary Completion Date:	April 2031
Study Completion Date:	April 2031
Condition:	Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, NC	Wilmington, NC, United States of America, 28401

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.